Diverse Responses to Vascular Disrupting Agent Combretastatin A4 Phosphate: A Comparative Study in Rats with Hepatic and Subcutaneous Tumor Allografts Using MRI Biomarkers, Microangiography, and Histopathology-Reference-Cited by-同舟云学术

Diverse Responses to Vascular Disrupting Agent Combretastatin A4 Phosphate: A Comparative Study in Rats with Hepatic and Subcutaneous Tumor Allografts Using MRI Biomarkers, Microangiography, and Histopathology

Published:2013-02 Issue:1 Volume:6 Page:42-50
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Li Junjie,Chen Feng,Feng Yuanbo,Cona Marlein Miranda,Yu Jie,Verbruggen Alfons,Zhang Jian,Oyen Raymond,Ni Yicheng

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference50 articles.

1. A review on various targeted anticancer therapies;Li;Target Oncol,2012

2. Vascular targeting as a strategy for cancer therapy;Schnitzer;N Engl J Med,1998

3. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model;Arap;Science,1998

4. Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice;Ching;Br J Cancer,2004

5. Visualizing the acute effects of vascular-targeted therapy in vivo using intravital microscopy and magnetic resonance imaging: correlation with endothelial apoptosis, cytokine induction, and treatment outcome;Seshadri;Neoplasia,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation;Diagnostics;2020-01-31

2. The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery;Biomedicine & Pharmacotherapy;2019-01

3. Treatment of a malignant peripheral nerve sheath tumor by intravenous administration of combretastatin A4-phosphate in a dog;Vlaams Diergeneeskundig Tijdschrift;2018-12-28

4. Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers;World Journal of Gastroenterology;2018-07-07

5. Water-Soluble Combretastatin A4 Phosphate Orally Delivered via Composite Nanoparticles With Improved Inhibition Effect Toward S180 Tumors;Journal of Pharmaceutical Sciences;2017-10